Skip to main content
. 2018 Apr 10;146(7):832–838. doi: 10.1017/S0950268818000729

Table 2.

Epidemiological summary of symptomatic surveillance showing prevalence and overall burden from confirmed targets found in SNF 1 and SNF 2

Positive target detected Prevalence (%) Estimated number of annual casesa
SNF1 7 23.3 28
Para 3 4 13.3 16
Rhino/Entero 3 10.0 12
SNF2 3 16.6 12
Flu B 1 5.5 4
Rhino/Entero 1 5.5 4
RSV 1 5.5 4
a

Assuming period prevalence is sustained during a 12-month period.